128 related articles for article (PubMed ID: 22351865)
1. Decreased eNOS protein expression in involuting and propranolol-treated hemangiomas.
Dai Y; Hou F; Buckmiller L; Fan CY; Saad A; Suen J; Richter GT
Arch Otolaryngol Head Neck Surg; 2012 Feb; 138(2):177-82. PubMed ID: 22351865
[TBL] [Abstract][Full Text] [Related]
2. [Influences of gonadotropin releasing hormone agonist treatment on nitric oxide synthase expression in women with endometriosis and infertility].
Wang JH; Zhou FZ; Dong MY; Yuan L
Zhonghua Fu Chan Ke Za Zhi; 2005 Jun; 40(6):383-7. PubMed ID: 16008888
[TBL] [Abstract][Full Text] [Related]
3. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
[TBL] [Abstract][Full Text] [Related]
4. [The expression of CEACAM-1 and CXCL-14 in infantile hemangioma].
Xu GQ; Lü RR; Huo R; Guo X
Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 May; 26(3):195-8. PubMed ID: 20737948
[TBL] [Abstract][Full Text] [Related]
5. Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas.
Phillips JD; Zhang H; Wei T; Richter GT
JAMA Facial Plast Surg; 2017 Mar; 19(2):102-107. PubMed ID: 27737446
[TBL] [Abstract][Full Text] [Related]
6. Expression of glucocorticoid receptor isoforms in cutaneous hemangiomas and vascular malformations.
Jiang XW; Wang GH; Li JH; Chen ZX; He F
Chin Med J (Engl); 2005 Jun; 118(12):977-81. PubMed ID: 15978204
[TBL] [Abstract][Full Text] [Related]
7. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
[TBL] [Abstract][Full Text] [Related]
8. [Propranolol for the treatment of severe hemangiomas of infancy: results from a series of 28 patients].
Bernabeu-Wittel J; Pereyra-Rodríguez JJ; Mantrana-Bermejo ME; Fernández-Pineda I; de Agustín JC; Conejo-Mir J
Actas Dermosifiliogr; 2011 Sep; 102(7):510-6. PubMed ID: 21514550
[TBL] [Abstract][Full Text] [Related]
9. Propofol protects against high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells.
Zhu M; Chen J; Tan Z; Wang J
Anesth Analg; 2012 Feb; 114(2):303-9. PubMed ID: 22156331
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the role of serum vascular endothelial growth factor and urinary basic fibroblast growth factor in differential diagnosis of vascular anomalies].
Zhang L; Chen Q; Li D; Li XW; Wang HG; Li GZ
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1092-5. PubMed ID: 21609589
[TBL] [Abstract][Full Text] [Related]
11. Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients.
Yuan WL; Jin ZL; Wei JJ; Liu ZY; Xue L; Wang XK
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):656-61. PubMed ID: 23291092
[TBL] [Abstract][Full Text] [Related]
12. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.
Celik A; Tiryaki S; Musayev A; Kismali E; Levent E; Ergun O
J Drugs Dermatol; 2012 Jul; 11(7):808-11. PubMed ID: 22777220
[TBL] [Abstract][Full Text] [Related]
13. Propranolol reduces infantile hemangioma volume and vessel density.
Bingham MM; Saltzman B; Vo NJ; Perkins JA
Otolaryngol Head Neck Surg; 2012 Aug; 147(2):338-44. PubMed ID: 22691693
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].
Qin ZP; Liu XJ; Li KL; Zhou Q; Yang XJ; Zheng JW
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3130-4. PubMed ID: 20193276
[TBL] [Abstract][Full Text] [Related]
15. Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts.
Felaco M; Grilli A; De Lutiis MA; Patruno A; Libertini N; Taccardi AA; Di Napoli P; Di Giulio C; Barbacane R; Conti P
Ann Clin Lab Sci; 2001 Apr; 31(2):179-86. PubMed ID: 11337908
[TBL] [Abstract][Full Text] [Related]
16. Propranolol therapy for reducing the number of nasal infantile hemangioma invasive procedures.
Perkins JA; Chen BS; Saltzman B; Manning SC; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2014 Mar; 140(3):220-7. PubMed ID: 24557492
[TBL] [Abstract][Full Text] [Related]
17. Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells.
Li Y; Zheng J; Bird IM; Magness RR
Endothelium; 2005; 12(1-2):21-39. PubMed ID: 16036314
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of TRAIL protein and mRNA in hemangioma].
Lin H; Chen SH; Yin GQ; Li D; Liu QF
Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Mar; 23(2):93-6. PubMed ID: 17554866
[TBL] [Abstract][Full Text] [Related]
19. Evolving treatments in the management of laryngotracheal hemangiomas: will propranolol supplant steroids and surgery?
Javia LR; Zur KB; Jacobs IN
Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1450-4. PubMed ID: 21880377
[TBL] [Abstract][Full Text] [Related]
20. [Effects of free fatty acids on nitric oxide synthase activity and mRNA expression in endothelial cell of SD rat aorta].
Yu YR; Li HL; Zhang XX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):193-6. PubMed ID: 18630681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
